Frontlight ResearchEarly access
Alzheimer disease trials in Russia
2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia
- Where
- Kazan', Moscow, Nizhny Novgorod, Roshchino, Rostov-on-Don, Saint Petersburg
- Age
- 60 years to 90 years
- People
- 450
- Run by
- Bigespas LTD
See details and how to joinNCT07251023 - No phaseTaking peopleThe Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
- Where
- Arkhangelsk, Astrakhan, Chelyabinsk, Chita, Kazan', Kemerovo, Krasnodar, Krasnoyarsk, Moscow, Nizhny Novgorod, Novosibirsk, Orenburg, Petrozavodsk, Rostov-on-Don, Saint Petersburg, Samara, Saratov, Stavropol, Tyumen, Vladivostok, Volgograd, Yakutsk, Yekaterinburg
- Age
- 18 years and over
- People
- 16,000
- Run by
- Russian Federation of Anesthesiologists and Reanimatologists
See details and how to joinNCT03945968